Vaccine pricing strategies in China.
作者信息
Zhang Haonan, Patenaude Bryan, Ma Chao, Fang Hai
机构信息
China Center for Health Development Studies, Peking University, Beijing, China.
Department of Health Policy and Management, Schoolf of Public Health, Peking University, Beijing, China.
出版信息
BMJ Glob Health. 2023 Jul;8(7). doi: 10.1136/bmjgh-2022-011405.
Abstract
摘要
相似文献
1
Vaccine pricing strategies in China.
BMJ Glob Health. 2023 Jul;8(7). doi: 10.1136/bmjgh-2022-011405.
2
Analytics for vaccine economics and pricing: insights and observations.
Expert Rev Vaccines. 2015 Apr;14(4):605-16. doi: 10.1586/14760584.2015.985662. Epub 2014 Dec 1.
3
Public support in the United States for global equity in vaccine pricing.
Sci Rep. 2022 May 27;12(1):8960. doi: 10.1038/s41598-022-13172-7.
4
Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 Pandemic.
Health Aff (Millwood). 2021 Jan;40(1):53-61. doi: 10.1377/hlthaff.2020.01548. Epub 2020 Nov 19.
5
Pricing of new vaccines.
Hum Vaccin. 2010 Aug;6(8):619-26. doi: 10.4161/hv.6.8.11563.
6
Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts.
Health Policy. 2016 May;120(5):519-34. doi: 10.1016/j.healthpol.2016.03.014. Epub 2016 Apr 12.
7
Tiered Pricing and Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the Literature.
Value Health Reg Issues. 2024 Jul;42:100981. doi: 10.1016/j.vhri.2024.01.003. Epub 2024 Apr 27.
8
A Call to Action Against Persistent Lack of Transparency in Vaccine Pricing Practices During the COVID-19 Pandemic.
Ann Glob Health. 2022 Oct 11;88(1):87. doi: 10.5334/aogh.3898. eCollection 2022.
9
[Mechanics and effects of European reference pricing for vaccines in Germany according to §130a Abs. 2 SGB V: an analysis using the example of influenza vaccines].
Gesundheitswesen. 2014 Apr;76(4):e7-e13. doi: 10.1055/s-0033-1351272. Epub 2013 Sep 30.
10
Designing pediatric vaccine formularies and pricing pediatric combination vaccines using operations research models and algorithms.
Expert Rev Vaccines. 2003 Feb;2(1):15-9. doi: 10.1586/14760584.2.1.15.
引用本文的文献
1
Service delivery costs of vaccination at health facilities in Guangzhou, China.
Hum Vaccin Immunother. 2025 Dec;21(1):2545031. doi: 10.1080/21645515.2025.2545031. Epub 2025 Aug 18.
2
Public Preference and Priorities for Including Vaccines in China's National Immunization Program: Discrete Choice Experiment.
JMIR Public Health Surveill. 2024 Nov 14;10:e57798. doi: 10.2196/57798.
3
The equity road ahead for financing non-national immunization program vaccines in China: challenges and opportunities from a qualitative study.
Int J Equity Health. 2024 Sep 27;23(1):193. doi: 10.1186/s12939-024-02282-5.
4
Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2313860. doi: 10.1080/21645515.2024.2313860. Epub 2024 Feb 15.
5
Adding new childhood vaccines to China's National Immunization Program: evidence, benefits, and priorities.
Lancet Public Health. 2023 Dec;8(12):e1016-e1024. doi: 10.1016/S2468-2667(23)00248-7.
本文引用的文献
1
Coverage and Equity of Childhood Vaccines in China.
JAMA Netw Open. 2022 Dec 1;5(12):e2246005. doi: 10.1001/jamanetworkopen.2022.46005.
2
A guideline for economic evaluations of vaccines and immunization programs in China.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2132802. doi: 10.1080/21645515.2022.2132802. Epub 2022 Oct 26.
3
Prioritization of Vaccines for Inclusion into China's Expanded Program on Immunization: Evidence from Experts' Knowledge and Opinions.
Vaccines (Basel). 2022 Jun 24;10(7):1010. doi: 10.3390/vaccines10071010.
4
Measuring parents' acceptance of non-national immunization program vaccines for children and its influencing factors during the COVID-19 pandemic in Shanghai, China.
Hum Vaccin Immunother. 2022 Nov 30;18(5):2069427. doi: 10.1080/21645515.2022.2069427. Epub 2022 Jun 21.
5
Vaccine bidding, procurement and distribution management practices in mainland China: A nationwide study.
Vaccine. 2021 Dec 20;39(52):7584-7589. doi: 10.1016/j.vaccine.2021.11.020. Epub 2021 Nov 19.
6
Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China.
BMJ Glob Health. 2021 Sep;6(9). doi: 10.1136/bmjgh-2021-005519.
7
Vaccine purchasing groups in the United States: An overview of their policies and practices.
Vaccine. 2016 Sep 30;34(42):5060-5065. doi: 10.1016/j.vaccine.2016.08.080. Epub 2016 Sep 7.
8
The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness.
Health Aff (Millwood). 2016 Feb;35(2):212-8. doi: 10.1377/hlthaff.2015.1088.
9
Pricing of new vaccines.
Hum Vaccin. 2010 Aug;6(8):619-26. doi: 10.4161/hv.6.8.11563.
Zotero 插件